Antiinflamatórios não-esteroidais e sua farmacologia local
DOI:
https://doi.org/10.11606/issn.2317-0190.v16i4a103285Palavras-chave:
Farmacologia, Antiinflamatórios não Esteróides, Ferimentos e Lesões/reabilitaçãoResumo
Os antiinflamatórios não-esteroidais (AINES) são geralmente usados para reduzir a dor e inflamação resultantes de diversos tipos de lesões. Apesar de normalmente serem administrados por via oral, seu uso local tem atraído a atenção de profissionais da área médica e de pesquisadores interessados em comprovar a disponibilidade aumentada desses medicamentos em locais próximos a área lesionada. A presente revisão enfatiza a terapia local, principalmente a via intradérmica, como uma alternativa altamente promissora para a administração de AINES.
Downloads
Referências
Insel PA. Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout. In: Hardman JG, Gilman AG, Limbird LE. Goodman & Gilman's. The pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill; 2005. p. 2021.
Serhan CN, Chiang N. Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics. Rheum Dis Clin North Am. 2004;30(1):69-95.
Rang HP, Dale MM, Ritter JM, Flower RJ. Farmacologia com student consult. 6th ed. Rio de Janeiro: Elsevier; 2007.
Serhan CN, Oliw E. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest. 2001;107(12):1481-9.
Fu JY, Masferrer JL, Seibert K, Raz A, Needleman P. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem. 1990;265(28):16737-40.
Chou R, Helfand M, Peterson K, Dana T, Roberts C. Drug Class Review on Cyclooxygenase (COX)-2 Inhibitors and Non-steroidal Anti-inflammatory Drugs (NSAIDs). Portland: Oregon Health & Science University; 2006.
Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/ antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci U S A. 2002;99(21):13926-31.
Davies NM, Good RL, Roupe KA, Yáñez JA. Cyclooxygenase-3: axiom, dogma, anomaly, enigma or splice error?--Not as easy as 1, 2, 3. J Pharm Pharm Sci. 2004;7(2):217-26.
Feldman M, McMahon AT. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med. 2000;132(2):134-43.
Berenbaum F. New horizons and perspectives in the treatment of osteoarthritis. Arthritis Res Ther. 2008;10 Suppl 2:S1-7.
Weideman RA, Kelly KC, Kazi S, Cung A, Roberts KW, Smith HJ, et al. Risks of clinically significant upper gastrointestinal events with etodolac and naproxen: a historical cohort analysis. Gastroenterology. 2004;127(5):1322-8.
Goldkind L, Laine L. A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience. Pharmacoepidemiol Drug Saf. 2006;15(4):213-20.
Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, Horgan K, et al. Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. N Engl J Med. 2005;352(11):1092-102.
Solomon SD, McMurray JJ, Pfeffer MA, Wittes J, Fowler R, Finn P, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med. 2005;352(11):1071-80.
Solignac M. Assessment of a topical NSAIDs in the treatment of pain and inflammation. The example of Flector Plaster, a local bioadhesive plaster containing diclofenac epolamine. Presse Med. 2004;33(14 Pt 2):3S10-3.
Petersen B, Rovati S. Diclofenac epolamine (Flector) patch: evidence for topical activity. Clin Drug Investig. 2009;29(1):1-9.
Sarigüllü Ozgüney I, Yeşim Karasulu H, Kantarci G, Sözer S, Güneri T, Ertan G. Transdermal delivery of diclofenac sodium through rat skin from various formulations. AAPS PharmSciTech. 2006;7(4):88.
McNeill SC, Potts RO, Francoeur ML. Local enhanced topical delivery (LETD) of drugs: does it truly exist? Pharm Res. 1992;9(11):1422-7.
Higaki K, Asai M, Suyama T, Nakayama K, Ogawara K, Kimura T. Estimation of intradermal disposition kinetics of drugs: II. Factors determining penetration of drugs from viable skin to muscular layer. Int J Pharm. 2002;239(1-2):129-41.
Higaki K, Nakayama K, Suyama T, Amnuaikit C, Ogawara K, Kimura T. Enhancement of topical delivery of drugs via direct penetration by reducing blood flow rate in skin. Int J Pharm. 2005;288(2):227-33.
Zacher J, Altman R, Bellamy N, Brühlmann P, Da Silva J, Huskisson E, et al. Topical diclofenac and its role in pain and inflammation: an evidence-based review. Curr Med Res Opin. 2008;24(4):925-50.
Heyneman CA, Lawless-Liday C, Wall GC. Oral versus topical NSAIDs in rheumatic diseases: a comparison. Drugs. 2000;60(3):555-74.
Russell AL. Piroxicam 0.5% topical gel compared to placebo in the treatment of acute soft tissue injuries: a double-blind study comparing efficacy and safety. Clin Invest Med. 1991;14(1):35-43.
Brühlmann P, de Vathaire F, Dreiser RL, Michel BA. Short-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomised clinical studies. Curr Med Res Opin. 2006;22(12):2429-38.
Joussellin E. Flector Tissugel® in the treatment of painful ankle sprain. J Traumatol Sport. 2003;20:1S5-9.
Petersen B, Rovati S. Diclofenac epolamine (Flector) patch: evidence for topical activity. Clin Drug Investig. 2009;29(1):1-9.
Mazières B, Rouanet S, Velicy J, Scarsi C, Reiner V. Topical ketoprofen patch (100 mg) for the treatment of ankle sprain: a randomized, double-blind, placebo-controlled study. Am J Sports Med. 2005;33(4):515-23.
Esparza F, Cobián C, Jiménez JF, García-Cota JJ, Sánchez C, Maestro A, et al. Topical ketoprofen TDS patch versus diclofenac gel: efficacy and tolerability in benign sport related soft-tissue injuries. Br J Sports Med. 2007;41(3):134-9.
Lundell JC, Silverman DG, Brull SJ, O'Connor TZ, Kitahata LM, Collins JG, et al. Reduction of postburn hyperalgesia after local injection of ketorolac in healthy volunteers. Anesthesiology. 1996;84(3):502-9.
Dogrul A, Gülmez SE, Deveci MS, Gul H, Ossipov MH, Porreca F, et al. The local antinociceptive actions of nonsteroidal antiinflammatory drugs in the mouse radiant heat tail-flick test. Anesth Analg. 2007;104(4):927-35.
Pistor M. What is mesotherapy. Chir Dent Fr. 1976;46(288):59-60.
Corbel D. Initiation à l' ID-thérapie mésothérapie. Paris: SIMEP; 1989.
Metsavaht L, Metsavaht O, Knackfuss I, De Gervais J. Mesoterapia para o tratamento da epicondilite lateral no cotovelo. Med Reabil. 1998;48:23-6.
Metsavaht L, Metsavaht O, Neto VG, Knackfuss, I. Mesoterapia nas tedinites do maguito dos rotadores do ombro. Med Reabil. 1999;50:17-22.
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2009 Acta Fisiátrica
Este trabalho está licenciado sob uma licença Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
